Phase II Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2017
At a glance
- Drugs Bendamustine (Primary) ; Ofatumumab (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 19 Apr 2017 Status changed from active, no longer recruiting to completed.
- 22 Dec 2016 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.
- 10 Oct 2016 Planned End Date changed from 1 Oct 2016 to 1 Dec 2016.